Skip to main content

Verition Fund Management LLC

SEC CIK
0001454027
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Verition Fund Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
22,500
Value
$842.0K
% of portfolio
<0.1%
Quarters held
4
Since Q4 2024
Holdings of CRNX by Verition Fund Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,500$842.0K<0.1%+22,500NewHolders
Q3 20250$00.0%−95,333−100.0%Sold outHolders
Q2 202595,333$2.74M<0.1%+68,875+260.3%AddedHolders
Q1 202526,458$887.4K<0.1%+9,241+53.7%AddedHolders
Q4 202417,217$880.3K<0.1%+17,217NewHolders